Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Quality of life, anxiety and depression in adult patients after add-on of levetiracetam and conversion to levetiracetam monotherapy.

Hagemann A, May TW, Nieder E, Witte-Bölt K, Pohlmann-Eden B, Elger CE, Tergau F, Schulze-Bonhage A, Straub HB, Arnold S, Brandt C.

Epilepsy Res. 2013 Mar;104(1-2):140-50. doi: 10.1016/j.eplepsyres.2012.08.005. Epub 2012 Sep 6.

PMID:
22959715
3.

Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.

Maschio M, Zarabla A, Maialetti A, Fabi A, Vidiri A, Villani V, Giannarelli D.

Epilepsy Behav. 2017 Aug;73:83-89. doi: 10.1016/j.yebeh.2017.05.031. Epub 2017 Jun 14.

PMID:
28623754
4.

Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.

Peltola J, Coetzee C, Jiménez F, Litovchenko T, Ramaratnam S, Zaslavaskiy L, Lu ZS, Sykes DM; Levetiracetam XR N01235 Study Group.

Epilepsia. 2009 Mar;50(3):406-14. doi: 10.1111/j.1528-1167.2008.01817.x.

5.

The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.

Steinhoff BJ, Somerville ER, Van Paesschen W, Ryvlin P, Schelstraete I.

Epilepsy Res. 2007 Aug;76(1):6-14. Epub 2007 Aug 6.

PMID:
17681453
6.

Effect of levetiracetam on epilepsy-related quality of life. N132 Study Group.

Cramer JA, Arrigo C, Van Hammée G, Gauer LJ, Cereghino JJ.

Epilepsia. 2000 Jul;41(7):868-74.

7.

Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.

Delanty N, Jones J, Tonner F.

Epilepsia. 2012 Jan;53(1):111-9. doi: 10.1111/j.1528-1167.2011.03300.x. Epub 2011 Nov 2.

8.

Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy.

Ben-Menachem E, Edrich P, Van Vleymen B, Sander JW, Schmidt B.

Epilepsy Res. 2003 Feb;53(1-2):57-64.

PMID:
12576168
9.

Maintenance of improvement in health-related quality of life during long-term treatment with levetiracetam.

Cramer JA, Van Hammée G; N132 Study Group.

Epilepsy Behav. 2003 Apr;4(2):118-23.

PMID:
12697135
10.

Levetiracetam monotherapy for elderly patients with epilepsy.

Alsaadi TM, Koopmans S, Apperson M, Farias S.

Seizure. 2004 Jan;13(1):58-60.

11.

Effect of levetiracetam on cognitive functions and quality of life: a one-year follow-up study.

López-Góngora M, Martínez-Domeño A, García C, Escartín A.

Epileptic Disord. 2008 Dec;10(4):297-305. doi: 10.1684/epd.2008.0227.

12.

Serum concentrations of Levetiracetam in epileptic patients: the influence of dose and co-medication.

May TW, Rambeck B, Jürgens U.

Ther Drug Monit. 2003 Dec;25(6):690-9.

PMID:
14639055
13.

Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery.

Milligan TA, Hurwitz S, Bromfield EB.

Neurology. 2008 Aug 26;71(9):665-9. doi: 10.1212/01.wnl.0000324624.52935.46.

PMID:
18725591
14.

Loss of the initial efficacy of levetiracetam in patients with refractory epilepsy.

Lee GH, Kim BM, Kang JK, Lee SA.

Seizure. 2013 Apr;22(3):185-8. doi: 10.1016/j.seizure.2012.12.002. Epub 2012 Dec 30.

15.

Effects of levetiracetam on generalized discharges monitored with ambulatory EEG in epileptic patients.

Pro S, Vicenzini E, Pulitano P, Li Voti P, Zarabla A, Randi F, Mecarelli O.

Seizure. 2009 Mar;18(2):133-8. doi: 10.1016/j.seizure.2008.08.004. Epub 2008 Oct 2.

16.

Levetiracetam for people with mental retardation and refractory epilepsy.

Kelly K, Stephen LJ, Brodie MJ.

Epilepsy Behav. 2004 Dec;5(6):878-83.

PMID:
15582836
17.

Cognitive outcome of antiepileptic treatment with levetiracetam versus carbamazepine monotherapy: a non-interventional surveillance trial.

Helmstaedter C, Witt JA.

Epilepsy Behav. 2010 May;18(1-2):74-80. doi: 10.1016/j.yebeh.2010.02.011. Epub 2010 May 13.

PMID:
20462801
18.

Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures.

Zhou B, Zhang Q, Tian L, Xiao J, Stefan H, Zhou D.

Epilepsy Behav. 2008 Feb;12(2):305-10. Epub 2007 Nov 19.

PMID:
18024209
19.

[Efficacy and safety of levetiracetam (keppra) add-on treatment in adult patients with refractory epilepsy in two tertiary centers].

Auriel E, Chistik V, Blatt I, Margolin N, Neufeld M.

Harefuah. 2007 Apr;146(4):269-71, 318. Hebrew.

PMID:
17476932
20.

Levetiracetam in clinical practice: efficacy and tolerability in epilepsy.

Bilo L, de Leva MF, Meo R.

Can J Neurol Sci. 2010 May;37(3):376-82.

PMID:
20481273

Supplemental Content

Support Center